Drug Notebook

FDA Alerts

    Alterations in Anticoagulant Effects
  • Altered coagulation parameters (e.g., increased PT, increased INR) and/or bleeding, sometimes fatal, reported in patients, with or without liver metastases, receiving capecitabine concomitantly with coumarin-derivative anticoagulants. Generally occurs within several days to months following initiation of therapy, but has been reported within 1 month following discontinuance of therapy. (See Coagulopathy under Cautions and also see Specific Drugs under Interactions.)
  • Age >60 years and diagnosis of cancer may independently increase risk of coagulopathy.
  • Monitor anticoagulant response (PT or INR) frequently in patients receiving concomitant capecitabine and oral coumarin-derivative therapy; adjust anticoagulant dosage accordingly.

Drug Info Tools
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Licensed from
capecitabine
Page: 1 2 3 Next >
(cah peh SIGH tah bean)

What is the most important information I should know about capecitabine?

Capecitabine should only be prescribed by a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.

Talk to your doctor if you are taking the blood thinner warfarin (Coumadin). In some cases, severe bleeding and death have resulted when these medications were taken together, or when treatment with warfarin (Coumadin) was started in the month following treatment with capecitabine. If treatment with both medications is determined by your doctor to be necessary, special monitoring will be required.

If the dose of capecitabine prescribed for you requires a combination of different strength tablets, it is very important that you correctly identify the tablets to ensure the correct dose. Contact your doctor or pharmacist if you have questions regarding a dose.

Stop taking capecitabine and notify your doctor immediately if you experience any of the following side effects: more than 4 bowel movements per day or diarrhea at night; vomiting more than once in a 24-hour period; the amount of food you eat each day is much less than usual or if you are only able to eat at certain times; pain, redness, swelling, or sores in or around the mouth; tingling, numbness, pain, swelling, or redness of the hands and/or feet (hand-and-foot syndrome); or fever (temperature greater than 100.5 degrees) or other evidence of infection.

What is capecitabine?

Capecitabine is a cancer (chemotherapeutic) medication. Capecitabine interferes with the growth of cancer cells and slows their growth and spread in the body.

Capecitabine is used in the treatment of some types of breast and colorectal cancers.

Capecitabine may also be used for purposes other than those listed in this medication guide.

What should I discuss with my healthcare provider before taking capecitabine?

Do not take capecitabine without first talking to your doctor if you are allergic to fluorouracil (Adrucil).

Before taking capecitabine, tell your doctor if you

You may not be able to take capecitabine, or you may require a dosage adjustment or special monitoring during therapy if you have any of the conditions listed above.

Do not take this medication if you are pregnant or could become pregnant during treatment. Capecitabine is in the FDA pregnancy category D. This means that it is known to cause birth defects in an unborn baby. Contraceptive measures are recommended for both men and women during treatment with capecitabine. It is not known whether capecitabine will harm a nursing infant. Do not take capecitabine without first talking to your doctor if you are breast-feeding. The safety and effectiveness of capecitabine in patients younger than 18 years of age have not been established. If you are over the age of 80, you may be more likely to experience side effects from capecitabine.
Page: 1 2 3 Next >
Related Learning
Centers
Advertisement
Back to Top